![Napsin A RMab EP205](http://www.diagnostictechnology.com.au/cdn/shop/products/BioSB-Logo-288pxW_9ae0af0e-c5b8-42ef-9dee-abf3a86bb67b_1024x1024.png?v=1493190344)
Napsin A RMab EP205
BSB 6988-BSB 6994Contact us for more information.
The activation peptides of aspartic proteinases play a role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional glycosylated aspartic proteinase precursor containg an RGD motif and an addition 18 residues at its C-terminus. In normal tissue, anti-Napsin A labels type II pneumocytes in adult lung and epithelial cells in kidney tissues. In abnormal tissues, Napsin A is a useful marker for lung adenocarcinoma.
Available options include prediluted (3ml, 7 ml, 15ml), concentrate (0.1 ml, 0.5ml, 1ml) and 5+ control slides.
For Research Use Only.